Russell Z. Szmulewitz to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Russell Z. Szmulewitz has written about Xenograft Model Antitumor Assays.
Connection Strength
0.139
-
Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer. Horm Cancer. 2014 Apr; 5(2):72-89.
Score: 0.108
-
Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer. Oncotarget. 2016 May 03; 7(18):26259-74.
Score: 0.031